✦ LIBER ✦

Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: A review of their methodologies and results

✍ Scribed by D. H. Solomon; E. Mercer; A. Kavanaugh

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 184 KB
Volume: 64
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.30653

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with tumor necrosis factor inh

Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis

✍ Lotta Ljung; Julia F. Simard; Lennart Jacobsson; Solbritt Rantapää-Dahlqvist; Jo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 2 views

## Abstract ## Objective Rheumatoid arthritis (RA) is associated with an increased risk of ischemic heart disease, in both early and established RA. Data on the risk of ischemic heart disease in relation to therapy with tumor necrosis factor (TNF) antagonists (anti‐TNF) are conflicting in patients

Association between the level of circula

Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at −308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor

✍ Hubert Marotte; Béatrice Arnaud; Jennifer Diasparra; Saloua Zrioual; Pierre Mios 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

The comparative one-year performance of

The comparative one-year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study

✍ Heiberg, Marte Schrumpf ;Koldingsnes, Wenche ;Mikkelsen, Knut ;Rødevand, Erik ;K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

Evaluation of the safety of rituximab in

Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial

✍ Maria W. Greenwald; William J. Shergy; Jeffrey L. Kaine; Marianne T. Sweetser; K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

Treatment of rheumatoid arthritis with t

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report

✍ Juan J. Gómez-Reino; Loreto Carmona; Vicente Rodríguez Valverde; Emilio Martín M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Cancer risk in patients with rheumatoid

Cancer risk in patients with rheumatoid arthritis treated with anti–tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?

✍ Johan Askling; Ronald F. van Vollenhoven; Fredrik Granath; Pauline Raaschou; C. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views